Total Liabilities: The total value of all possible claims against the corporation.
Dianthus Therapeutics, Inc. (DNTH) had Total Liabilities of $23.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.19M |
|
$-31.63M |
|
-- |
|
$0.19M |
|
$35.12M |
|
$-34.93M |
|
$3.30M |
|
$-31.63M |
|
$-31.66M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
$-31.66M |
|
$-34.93M |
|
$-35.93M |
|
35.82M |
|
35.82M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$263.61M |
|
$0.21M |
|
$62.47M |
|
$326.08M |
|
$20.09M |
|
-- |
|
$2.90M |
|
|
Total Liabilities |
$23.00M |
$303.08M |
|
$303.08M |
|
$303.08M |
|
32.18M |
|
| Cash Flow Statement Financials | |
$-51.52M |
|
$41.24M |
|
$0.73M |
|
$23.02M |
|
$13.47M |
|
$-9.55M |
|
$11.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-18096.89% |
|
-18096.89% |
|
-- |
|
-16388.08% |
|
-16388.08% |
|
$-51.59M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
4.95 |
|
18.19 |
|
-10.44% |
|
-10.44% |
|
-9.70% |
|
-10.44% |
|
$9.42 |
|
$-1.44 |
|
$-1.44 |
|